These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 30067223)

  • 1. Thalidomide promotes degradation of SALL4, a transcription factor implicated in Duane Radial Ray syndrome.
    Donovan KA; An J; Nowak RP; Yuan JC; Fink EC; Berry BC; Ebert BL; Fischer ES
    Elife; 2018 Aug; 7():. PubMed ID: 30067223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SALL4 mediates teratogenicity as a thalidomide-dependent cereblon substrate.
    Matyskiela ME; Couto S; Zheng X; Lu G; Hui J; Stamp K; Drew C; Ren Y; Wang M; Carpenter A; Lee CW; Clayton T; Fang W; Lu CC; Riley M; Abdubek P; Blease K; Hartke J; Kumar G; Vessey R; Rolfe M; Hamann LG; Chamberlain PP
    Nat Chem Biol; 2018 Oct; 14(10):981-987. PubMed ID: 30190590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defining the human C2H2 zinc finger degrome targeted by thalidomide analogs through CRBN.
    Sievers QL; Petzold G; Bunker RD; Renneville A; Słabicki M; Liddicoat BJ; Abdulrahman W; Mikkelsen T; Ebert BL; Thomä NH
    Science; 2018 Nov; 362(6414):. PubMed ID: 30385546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thalidomide Inhibits Human iPSC Mesendoderm Differentiation by Modulating CRBN-dependent Degradation of SALL4.
    Belair DG; Lu G; Waller LE; Gustin JA; Collins ND; Kolaja KL
    Sci Rep; 2020 Feb; 10(1):2864. PubMed ID: 32071327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural bases of IMiD selectivity that emerges by 5-hydroxythalidomide.
    Furihata H; Yamanaka S; Honda T; Miyauchi Y; Asano A; Shibata N; Tanokura M; Sawasaki T; Miyakawa T
    Nat Commun; 2020 Sep; 11(1):4578. PubMed ID: 32929090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal structure of the SALL4-pomalidomide-cereblon-DDB1 complex.
    Matyskiela ME; Clayton T; Zheng X; Mayne C; Tran E; Carpenter A; Pagarigan B; McDonald J; Rolfe M; Hamann LG; Lu G; Chamberlain PP
    Nat Struct Mol Biol; 2020 Apr; 27(4):319-322. PubMed ID: 32251415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SALL4 mutations in Okihiro syndrome (Duane-radial ray syndrome), acro-renal-ocular syndrome, and related disorders.
    Kohlhase J; Chitayat D; Kotzot D; Ceylaner S; Froster UG; Fuchs S; Montgomery T; Rösler B
    Hum Mutat; 2005 Sep; 26(3):176-83. PubMed ID: 16086360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of ESCO2, SALL4 and TBX5 genes in the susceptibility to thalidomide teratogenesis.
    Gomes JDA; Kowalski TW; Fraga LR; Macedo GS; Sanseverino MTV; Schuler-Faccini L; Vianna FSL
    Sci Rep; 2019 Aug; 9(1):11413. PubMed ID: 31388035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thalidomide and its metabolite 5-hydroxythalidomide induce teratogenicity via the cereblon neosubstrate PLZF.
    Yamanaka S; Murai H; Saito D; Abe G; Tokunaga E; Iwasaki T; Takahashi H; Takeda H; Suzuki T; Shibata N; Tamura K; Sawasaki T
    EMBO J; 2021 Feb; 40(4):e105375. PubMed ID: 33470442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure of the DDB1-CRBN E3 ubiquitin ligase in complex with thalidomide.
    Fischer ES; Böhm K; Lydeard JR; Yang H; Stadler MB; Cavadini S; Nagel J; Serluca F; Acker V; Lingaraju GM; Tichkule RB; Schebesta M; Forrester WC; Schirle M; Hassiepen U; Ottl J; Hild M; Beckwith RE; Harper JW; Jenkins JL; Thomä NH
    Nature; 2014 Aug; 512(7512):49-53. PubMed ID: 25043012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations at the SALL4 locus on chromosome 20 result in a range of clinically overlapping phenotypes, including Okihiro syndrome, Holt-Oram syndrome, acro-renal-ocular syndrome, and patients previously reported to represent thalidomide embryopathy.
    Kohlhase J; Schubert L; Liebers M; Rauch A; Becker K; Mohammed SN; Newbury-Ecob R; Reardon W
    J Med Genet; 2003 Jul; 40(7):473-8. PubMed ID: 12843316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic Analyses Identified a SALL4 Gene Mutation Associated with Holt-Oram Syndrome.
    Li B; Chen S; Sun K; Xu R; Wu Y
    DNA Cell Biol; 2018 Apr; 37(4):398-404. PubMed ID: 29461882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The myeloma drug lenalidomide promotes the cereblon-dependent destruction of Ikaros proteins.
    Lu G; Middleton RE; Sun H; Naniong M; Ott CJ; Mitsiades CS; Wong KK; Bradner JE; Kaelin WG
    Science; 2014 Jan; 343(6168):305-9. PubMed ID: 24292623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure of SALL4 zinc finger domain reveals link between AT-rich DNA binding and Okihiro syndrome.
    Watson JA; Pantier R; Jayachandran U; Chhatbar K; Alexander-Howden B; Kruusvee V; Prendecki M; Bird A; Cook AG
    Life Sci Alliance; 2023 Mar; 6(3):. PubMed ID: 36635047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KLF13 is a genetic modifier of the Holt-Oram syndrome gene TBX5.
    Darwich R; Li W; Yamak A; Komati H; Andelfinger G; Sun K; Nemer M
    Hum Mol Genet; 2017 Mar; 26(5):942-954. PubMed ID: 28164238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Teratogenic effects of thalidomide: molecular mechanisms.
    Ito T; Ando H; Handa H
    Cell Mol Life Sci; 2011 May; 68(9):1569-79. PubMed ID: 21207098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrative Role of the SALL4 Gene: From Thalidomide Embryopathy to Genetic Defects of the Upper Limb, Internal Organs, Cerebral Midline, and Pituitary.
    Kodytková A; Dušátková P; Amaratunga SA; Plachý L; Průhová Š; Lebl J
    Horm Res Paediatr; 2024; 97(2):106-112. PubMed ID: 37285827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-box genes and retinoic acid signaling regulate the segregation of arterial and venous pole progenitor cells in the murine second heart field.
    De Bono C; Thellier C; Bertrand N; Sturny R; Jullian E; Cortes C; Stefanovic S; Zaffran S; Théveniau-Ruissy M; Kelly RG
    Hum Mol Genet; 2018 Nov; 27(21):3747-3760. PubMed ID: 30016433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A New Strategy for the Old Challenge of Thalidomide: Systems Biology Prioritization of Potential Immunomodulatory Drug (IMiD)-Targeted Transcription Factors.
    Kowalski TW; Feira MF; Lord VO; Gomes JDA; Giudicelli GC; Fraga LR; Sanseverino MTV; Recamonde-Mendoza M; Schuler-Faccini L; Vianna FSL
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The teratogenic effects of thalidomide on limbs.
    Vargesson N
    J Hand Surg Eur Vol; 2019 Jan; 44(1):88-95. PubMed ID: 30335598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.